跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 10,721 条关于
“YCANTH (VP-102)”
全部
10,721
临床试验
4,829
药物
4,399
机构
15
资讯
1,478
11个月前
Verrica to Present VP-315 Immune Activation Data from Phase 2 Basal Cell Carcinoma Trial at SITC 2025
去年
Verrica Pharmaceuticals Launches Global Phase 3 Trial for YCANTH in Common Warts, Targeting 22 Million US Patients
2个月前
Verrica Doses First U.S. and Japanese Patients in Phase 3 COVE-3 Trial of YCANTH for Common Warts
去年
Torii Pharmaceutical Submits NDA in Japan for Verrica's Molluscum Contagiosum Treatment, TO-208
9个月前
Verrica Pharmaceuticals Secures $50 Million Financing to Advance Dermatology Pipeline and Eliminate Debt
去年
Verrica Pharmaceuticals Reports Record Growth in YCANTH® Dispensed Units for Molluscum Contagiosum Treatment
8个月前
Verrica Pharmaceuticals Initiates Phase 3 Trial for VP-102 in Common Warts Treatment
11个月前
Verrica Pharmaceuticals Receives EMA Support for YCANTH European Approval Without Additional Phase 3 Studies
4年前
FDA Approves Verrica's Ycanth, First Treatment for Molluscum Contagiosum
去年
Tonix Pharmaceuticals Bolsters Leadership as TNX-102 SL Awaits FDA Decision for Fibromyalgia
第 1 页,共 148 页
上一页
下一页